The guidance on the use of oral SACT for patients unable to swallow has been released!

Administration of oral systemic anticancer therapy (SACT) via enteral feeding tubes and other methods (Version 2)

This document replaces one in the Oral SACT Counselling Handbook for Pharmacy and Nursing staff (LCA, 2015) – patients with swallowing difficulties.

We would like to thank a team of Specialist Cancer Pharmacists and Medicines Information Pharmacists, who took the time to review each monograph using the latest evidence. This document is provided for informational purposes only and is intended to be used as a support tool. It should not determine your clinical decision making and it remains the responsibility of all medical professionals to use clinical judgement to make appropriate decisions.

Available here: https://www.bopa.org.uk/resources/administration-of-oral-sact-via-enteral-feeding-tube/

Kind regards,

Tiffany Chan and Sadia Malik
Lead Author/Editor of BOPA administration of oral SACT task and finish group

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article